Introduction
- 1 January 1986
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 16 (5) , 361-365
- https://doi.org/10.3109/00498258609050244
Abstract
(1986). Introduction. Xenobiotica: Vol. 16, No. 5, pp. 361-365. doi: 10.3109/00498258609050244Keywords
This publication has 15 references indexed in Scilit:
- ECOGENETICS OF PARKINSON'S DISEASE: 4-HYDROXYLATION OF DEBRISOQUINEThe Lancet, 1985
- Metabolic oxidation phenotypes as markers for susceptibility to lung cancerNature, 1984
- The genetic control of sparteine and debrisoquine metabolism in man with new methods of analysing bimodal distributions.Journal of Medical Genetics, 1983
- Deficient metabolism of debrisoquine and sparteineClinical Pharmacology & Therapeutics, 1980
- Pharmacogenetic covariation of defective N-oxidation of sparteine and 4-hydroxylation of debrisoquineEuropean Journal of Clinical Pharmacology, 1980
- Defective N-oxidation of sparteine in man: A new pharmacogenetic defectEuropean Journal of Clinical Pharmacology, 1979
- The Metabolism of Debrisoquine in Rat and ManBiochemical Society Transactions, 1976
- The Metabolism and Excretion of Guanoxan in ManXenobiotica, 1972
- The metabolic fate of amphetamine in man and other speciesBiochemical Journal, 1970
- C. Genetics of Man Enzyme polymorphisms in manProceedings of the Royal Society of London. B. Biological Sciences, 1966